skip to main content
Show Results with:

CD62L test at 2 years of natalizumab predicts progressive multifocal leukoencephalopathy

Pignolet, Béatrice et al.

Neurology. Volume 87:Number 23 (2016) -- Lippincott Williams & Wilkins

Online access

Searching Remote Databases, Please Wait